4//SEC Filing
Kosacz Barbara 4
Accession 0001415889-25-015434
CIK 0001620463other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:33 PM ET
Size
5.6 KB
Accession
0001415889-25-015434
Insider Transaction Report
Form 4
Kosacz Barbara
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-30+20,900→ 20,900 totalExercise: $0.31Exp: 2035-05-29→ Common Stock (20,900 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of (i) May 30, 2026, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 30, 2025. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001763316
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 5:33 PM ET
- Size
- 5.6 KB